These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 34175226)

  • 1. [Impact of neck dissection in N2-3 oropharyngeal squamous cell carcinomas treated with definitive chemoradiotherapy: An observational real-life study].
    Klausner G; Troussier I; Kreps S; Fabiano E; Laccourreye O; Giraud P
    Cancer Radiother; 2021 Dec; 25(8):771-778. PubMed ID: 34175226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer.
    Kawamoto T; Nihei K; Nakajima Y; Kito S; Sasai K; Karasawa K
    Auris Nasus Larynx; 2018 Oct; 45(5):1073-1079. PubMed ID: 29397249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma.
    Hutcheson KA; Abualsamh AR; Sosa A; Weber RS; Beadle BM; Sturgis EM; Lewin JS
    Head Neck; 2016 Jun; 38(6):886-93. PubMed ID: 26339764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Chera BS; Amdur RJ; Tepper JE; Tan X; Weiss J; Grilley-Olson JE; Hayes DN; Zanation A; Hackman TG; Patel S; Sheets N; Weissler MC; Mendenhall WM
    Cancer; 2018 Jun; 124(11):2347-2354. PubMed ID: 29579339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of very late dysphagia after chemoradiation for oropharyngeal squamous cell carcinoma.
    Gharzai LA; Li P; Schipper MJ; Yao J; Mayo CS; Wilkie JR; Hawkins PG; Lyden T; Blakely A; Ibrahim M; Schonewolf CA; Shah J; Eisbruch A; Casper K; Mierzwa M
    Oral Oncol; 2020 Dec; 111():104853. PubMed ID: 32805634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.
    Setton J; Lee NY; Riaz N; Huang SH; Waldron J; O'Sullivan B; Zhang Z; Shi W; Rosenthal DI; Hutcheson KA; Garden AS
    Cancer; 2015 Jan; 121(2):294-301. PubMed ID: 25286832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target volume definition for intensity-modulated radiotherapy after induction chemotherapy and patterns of treatment failure after sequential chemoradiotherapy in locoregionally advanced oropharyngeal squamous cell carcinoma.
    Loo SW; Geropantas K; Wilson P; Martin WM; Roques TW
    Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):162-70. PubMed ID: 22906546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck.
    Montejo ME; Shrieve DC; Bentz BG; Hunt JP; Buchman LO; Agarwal N; Hitchcock YJ
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e845-52. PubMed ID: 21167654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Study to Assess the Dosimetric Impact of the Anatomical Changes Occurring in the Parotid Glands and Tumour Volume during Intensity Modulated Radiotherapy using Simultaneous Integrated Boost (IMRT-SIB) in Head and Neck Squamous Cell Cancers.
    Ghosh A; Gupta S; Johny D; Vidyadhar Bhosale V; Pal Singh Negi M
    Cancer Med; 2021 Aug; 10(15):5175-5190. PubMed ID: 34159749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical results of definitive intensity-modulated radiation therapy for oropharyngeal cancer: retrospective analysis of treatment efficacy and safety.
    Kimura K; Kodaira T; Tomita N; Tachibana H; Makita C; Yoshida M; Nishikawa D; Hirakawa H; Suzuki H; Hanai N; Hasegawa Y
    Jpn J Clin Oncol; 2016 Jan; 46(1):78-85. PubMed ID: 26496935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Chera BS; Amdur RJ; Green R; Shen C; Gupta G; Tan X; Knowles M; Fried D; Hayes N; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Zevallos J; Blumberg J; Patel S; Kasibhatla M; Sheets N; Weissler M; Yarbrough W; Mendenhall W
    J Clin Oncol; 2019 Oct; 37(29):2661-2669. PubMed ID: 31411949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.
    Buchapudi RR; Manickam R; M R AK; C R TP; Chandraraj V; Pyakuryal A; Narayanasamy G
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2463-2470. PubMed ID: 31450921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial.
    Lang P; Contreras J; Kalman N; Paterson C; Bahig H; Billfalk-Kelly A; Brennan S; Rock K; Read N; Venkatesan V; Sathya J; Mendez LC; MacNeil SD; Nichols AC; Fung K; Mendez A; Winquist E; Kuruvilla S; Stewart P; Warner A; Mitchell S; Theurer JA; Palma DA
    Radiat Oncol; 2020 Aug; 15(1):196. PubMed ID: 32795322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial Design.
    Ward MC; Ross RB; Koyfman SA; Lorenz R; Lamarre ED; Scharpf J; Burkey BB; Joshi NP; Woody NM; Prendes B; Houston N; Reddy CA; Greskovich JF; Adelstein DJ
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1164-1170. PubMed ID: 27438230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Carboplatin/Paclitaxel-Based Radiochemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck.
    Maring S; Elsayad K; Stenner M; Rudack C; Haverkamp U; Rehkämper J; Wardelmann E; Eich HT
    Oncol Res Treat; 2018; 41(12):736-743. PubMed ID: 30419553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
    Maguire PD; Neal CR; Hardy SM; Schreiber AM
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1210-1216. PubMed ID: 29452770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
    Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.
    Tam M; Riaz N; Kannarunimit D; Peña AP; Schupak KD; Gelblum DY; Wolden SL; Rao S; Lee NY
    Am J Clin Oncol; 2015 Aug; 38(4):343-7. PubMed ID: 26208401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT.
    Miah AB; Gulliford SL; Bhide SA; Zaidi SH; Newbold KL; Harrington KJ; Nutting CM
    Radiother Oncol; 2013 Mar; 106(3):346-51. PubMed ID: 23540553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.